Citigroup’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.3K Sell
13,982
-6,225
-31% -$15.8K ﹤0.01% 5031
2026
Q1
$39.6K Buy
20,207
+9,592
+90% +$22.5K ﹤0.01% 4615
2025
Q4
$28.8K Sell
10,615
-794
-7% -$2.61K ﹤0.01% 4767
2025
Q3
$48.3K Buy
11,409
+6,021
+112% +$26.5K ﹤0.01% 4515
2025
Q2
$26.8K Buy
5,388
+495
+10% +$2.15K ﹤0.01% 5011
2025
Q1
$21.6K Buy
4,893
+733
+18% +$3.44K ﹤0.01% 5077
2024
Q4
$19.3K Buy
+4,160
New +$22.9K ﹤0.01% 5271
2023
Q4
Sell
-7,997
Closed -$45K 5760
2023
Q3
$45K Buy
7,997
+6,006
+302% +$40K ﹤0.01% 4176
2023
Q2
$11K Sell
1,991
-3,931
-66% -$21.2K ﹤0.01% 5052
2023
Q1
$37K Sell
5,922
-438
-7% -$2.44K ﹤0.01% 4342
2022
Q4
$29.6K Sell
6,360
-24,894
-80% -$123K ﹤0.01% 4453
2022
Q3
$146K Sell
31,254
-3,841
-11% -$24.2K ﹤0.01% 3915
2022
Q2
$208K Sell
35,095
-5,989
-15% -$66.7K ﹤0.01% 3829
2022
Q1
$794K Buy
41,084
+21,298
+108% +$488K ﹤0.01% 3160
2021
Q4
$647K Buy
19,786
+7,518
+61% +$302K ﹤0.01% 3625
2021
Q3
$502K Sell
12,268
-102,664
-89% -$3.72M ﹤0.01% 3605
2021
Q2
$4.14M Sell
114,932
-20,795
-15% -$767K ﹤0.01% 2060
2021
Q1
$5.3M Buy
135,727
+134,877
+15,868% +$6.07M ﹤0.01% 1744
2020
Q4
$34K Buy
+850
New +$39.1K ﹤0.01% 6303

Other funds holding GDRX

Citigroup's GDRX Position: Q2 2026 in Review

Citigroup reduced its GoodRx Holdings (GDRX) stake by 31% in Q2 2026, selling an estimated $15.8K and leaving 13,982 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5031.

Citigroup first reported a position in GDRX in Q4 2020 and has held it in 19 quarters since. The position peaked at $5.3M in Q1 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Citigroup held 13,982 shares of GoodRx Holdings worth $40.3K as of Q2 2026.
  • Citigroup sold 6,225 GoodRx Holdings shares in Q2 2026, an estimated $15.8K.
  • GoodRx Holdings made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5031 holding.
  • Citigroup first reported a position in GoodRx Holdings in Q4 2020 and has held it in 19 quarters since.
  • Citigroup's GoodRx Holdings position peaked at $5.3M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.